Helicobacter pylori, the leading cause of peptic ulcer disease and stomach cancer. One factor important to H. pylori infection is the pore-forming toxin VacA. It is thought to gain entry into host cells by binding to specialized ...
Apr 24, 2018
0
3
The make-up of the human gut flora is highly individual and extremely diverse. However, when a Helicobacter pylori infection is present, this bacterium displaces all other bacteria in the gastrointestinal tract, leaving only ...
Jan 23, 2018
0
5
A research team led by National University Health System (NUHS) and Duke-NUS Medical School has used genomic technologies to better understand intestinal metaplasia (IM), a known risk factor for gastric (stomach) cancer. ...
Jan 5, 2018
0
6
Different changes to the microbial community of the stomach may explain why related conditions are associated with different risk levels and types of gastric tumor, according to a new study in PLOS Pathogens.
Nov 2, 2017
0
0
(HealthDay)—Long-term proton pump inhibitor (PPI) use is associated with increased risk of gastric cancer (GC) even after Helicobacter pylori (HP) eradication therapy, according to a study published online Oct. 31 in Gut.
Nov 2, 2017
0
0
The long term use of proton pump inhibitors (PPIs), a class of drugs commonly used to treat acid reflux, is linked to a more than doubling in the risk of developing stomach cancer, finds research published online in the journal ...
Oct 31, 2017
0
35
The bacterium Helicobacter pylori is responsible for one of the most prevalent infections in humans. The infection can give rise to a number of conditions ranging from gastritis to peptic or duodenal ulcers and ultimately ...
Oct 25, 2017
0
1
It was long thought that gastric ulcers and other digestive woes were brought about by stress. But in 2005, clinical fellow Barry J. Marshall and pathologist J. Robin Warren were awarded the Nobel Prize in Physiology or Medicine ...
Jun 7, 2017
0
147
A new drug which "fine tunes" the immune system is being developed to help prevent asthma and allergies to foods such as peanuts and shellfish.
Nov 24, 2016
0
69
(HealthDay)—The potassium-competitive acid blocker vonoprazan-based triple therapy seems safe and effective compared with conventional proton pump inhibitor (PPI)-based triple therapy as first-line treatment against Helicobacter ...
Aug 25, 2016
0
0
